Home
/
PRECISION BIOSCIENCES INC
/
Financials
/
Quarterly
PRECISION BIOSCIENCES INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that PRECISION BIOSCIENCES INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$13.0K
Nov 3, 2025
Q2
2025
Jun 30, 2025
$18.0K
Aug 7, 2025
Q1
2025
Mar 31, 2025
$29.0K
May 15, 2025
Q3
2025
Sep 30, 2024
$576.0K
Nov 3, 2025
Q2
2025
Jun 30, 2024
$49.90M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$17.58M
May 15, 2025
Q3
2024
Sep 30, 2023
$13.12M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$19.79M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$8.78M
May 13, 2024
Q3
2023
Sep 30, 2022
$7.36M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$3.82M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$3.32M
May 9, 2023
Q3
2022
Sep 30, 2021
$24.04M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$68.81M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$16.35M
May 9, 2022
Q3
2021
Sep 30, 2020
$7.36M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$1.08M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$7.00M
May 13, 2021
Q3
2020
Sep 30, 2019
$4.87M
Nov 10, 2020
Q2
2020
Jun 30, 2019
$5.39M
Aug 13, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($21.77M)
Nov 3, 2025
Q3
2025
Jun 30, 2025
($23.52M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($23.52M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($20.57M)
May 15, 2025
Q3
2025
Mar 31, 2025
($20.57M)
Nov 3, 2025
Q2
2025
Mar 31, 2025
($20.57M)
Aug 7, 2025
Q3
2025
Sep 30, 2024
($16.43M)
Nov 3, 2025
Q3
2025
Jun 30, 2024
$32.75M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$32.75M
Aug 7, 2025
Q2
2025
Mar 31, 2024
$8.59M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$8.59M
May 15, 2025
Q3
2025
Mar 31, 2024
$8.59M
Nov 3, 2025
Q3
2024
Sep 30, 2023
($8.08M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($11.89M)
Aug 1, 2024
Q3
2024
Jun 30, 2023
($11.89M)
Nov 4, 2024
Q2
2024
Mar 31, 2023
($25.06M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($25.06M)
May 13, 2024
Q3
2024
Mar 31, 2023
($25.06M)
Nov 4, 2024
Q3
2023
Sep 30, 2022
($23.95M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($31.04M)
Aug 4, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($20.67M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($21.88M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($22.11M)
May 15, 2025
Q3
2025
Sep 30, 2024
($21.28M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
$24.15M
Aug 7, 2025
Q1
2025
Mar 31, 2024
($4.19M)
May 15, 2025
Q3
2024
Sep 30, 2023
($12.36M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($3.13M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($13.35M)
May 13, 2024
Q3
2023
Sep 30, 2022
($14.68M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($29.55M)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($27.34M)
May 9, 2023
Q3
2022
Sep 30, 2021
($11.54M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
$21.63M
Aug 8, 2022
Q1
2022
Mar 31, 2021
($18.74M)
May 9, 2022
Q3
2021
Sep 30, 2020
($26.04M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($32.81M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($27.50M)
May 13, 2021
Q3
2020
Sep 30, 2019
($21.98M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($23.87M)
Aug 13, 2020